🔗 Share this article

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer laws, risking penalties, legal action or prison.

Service Response and Content Removal

According to the social media company, the platform has removed violative material and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service secure and investing in strengthening enforcement strategies.

Digital Trading Operations

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, glowing testimonials and detailed instructions for mixing or administering at residence.

Within minutes of joining one group, a vendor shared contact information, where most transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Product Details and Costs

Within these groups, posts show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to possibly serious medical dangers”.